EU May Secure 50 Million More Moderna Vaccine Doses at a Premium
(Bloomberg) -- The European Union may secure an extra 50 million doses of the Covid-19 vaccine produced by Moderna Inc. as the bloc seeks to accelerate inoculations, according to people familiar with the matter.
The deal being arranged by the European Commission would bring to 210 million the total number of vaccine doses from Moderna for EU countries, with the additional supply costing 33% more than the 160 million doses covered by the original accord, said one of the people.
Another person said the amount and price of extra doses from Moderna could still change. Both people, speaking on the condition of anonymity because the agreement hasn’t been announced yet, said that some EU countries may opt out of buying any extra supply from the company and that delivery schedules for the extra jabs are unclear.
The commission’s health-policy spokesman, Stefan De Keersmaecker, declined to comment on the matter when reached on Thursday by telephone. A Moderna spokesperson also declined to comment.
The commission is pushing to approve Covid-19 vaccines and get them distributed across the 27-nation bloc, with safety evaluations slowing marketing authorizations and logistical challenges complicating deliveries.
The commission, the EU’s executive arm, has so far given the green light to two vaccines including Moderna’s. The other was developed by Pfizer Inc and BioNTech SE.
EU Drugs Agency May Decide on AstraZeneca Vaccine This Month
Before the planned extra supply from Moderna and a preliminary accord announced on Tuesday with Valneva SE for as many as 60 million doses, the commission had reached supply deals with various drug companies covering a total of around 2.3 billion doses.
©2021 Bloomberg L.P.